New antibody shows promise in reducing blood pressure meds for sepsis patients
NCT ID NCT06608901
First seen Nov 01, 2025 · Last updated May 25, 2026 · Updated 30 times
Summary
This study tested an experimental drug called REGN7544 in 76 adults hospitalized with sepsis and low blood pressure. The goal was to see if the drug could safely reduce the need for standard blood pressure medications (vasopressors). Researchers measured how much vasopressor patients needed and monitored side effects. The drug is not a cure but aims to better control blood pressure during sepsis.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEPSIS-INDUCED HYPOTENSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Atrium Health
Winston-Salem, North Carolina, 27157, United States
-
Bellevue Hospital
New York, New York, 10016, United States
-
CHU Dupuytren
Limoges, New Aquitaine, 87042, France
-
CHU Nantes
Nantes, 44093, France
-
CHU de Reims Hopital Robert Debre
Reims, 51100, France
-
Centre Hospitalier Departemental (CHD) Vendee
La Roche-sur-Yon, Vendee, 85925, France
-
Centre Hospitalier Le Mans
Le Mans, Pays de la Loire Region, 72037, France
-
Centre Hospitalier Regional Universaitaire de Tours (CHRU de Tours)
Tours, Centre-Val de Loire, 37000, France
-
Centre Hospitalier Universitaire Angers
Angers, 49933, France
-
Centre Hospitalier Universitaire d'Orleans
Orléans, 45064, France
-
Cleveland Clinic Foundation
Cleveland, Ohio, 44195, United States
-
Emory University Hospital
Atlanta, Georgia, 30322, United States
-
Harvard Medical School - Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02215, United States
-
Hopital Cochin
Paris, Île-de-France Region, 75014, France
-
Hopital Nord Franche Comte
Trévenans, 90400, France
-
Hopitaux Universitaires de Strasbourg
Strasbourg, 67091, France
-
Intermountain Medical Center - Murray (Pulmonary Medicine)
Murray, Utah, 84107, United States
-
Johns Hopkins Hospital
Baltimore, Maryland, 21287, United States
-
MUSC SCTR Research Nexus Clinic and Lab
Charleston, South Carolina, 29425, United States
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
-
Montefiore Medical Center - Moses Campus
The Bronx, New York, 10467, United States
-
Montefiore Medical Center - Weiler Hospital
The Bronx, New York, 10461, United States
-
New York University Langone Health Brooklyn Hospital
Brooklyn, New York, 11220, United States
-
New York University Langone Health Tisch-Kimmel Hospital
New York, New York, 10016, United States
-
Paris-Saclay University Hospitals
Le Kremlin-Bicêtre, 94270, France
-
Raymond Poincare University Hospital
Garches, 92380, France
-
University of Arizona
Tucson, Arizona, 85724, United States
-
Vanderbilt University Medical Center
Nashville, Tennessee, 37232, United States
-
Yale University
New Haven, Connecticut, 06510, United States
Conditions
Explore the condition pages connected to this study.